CD34 and acute lymphoblastic leukemia: The Ik-6+ ALL showed trends towards lower blast count (50% vs. 74%, p = 0.055), higher TdT (77% vs. 58.7%, p = 0.09), and less CD34 (59% vs. 80.1%, p = 0.161).